Ustekinumab trials for Psoriasis

All Ustekinumab trials · All Psoriasis trials

Phase breakdown

Recruiting trials studying Ustekinumab for Psoriasis

• Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
  NCT05270733 · Phase: Phase 4 · Ages: 18 Years to 89 Years · Sex: All (male and female) · 1 location
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · 402 locations
• Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
  NCT05725876 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
  NCT02103361 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 2 locations
• Swiss Dermatology Network of Targeted Therapies (SDNTT)
  NCT01706692 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

How many trials study Ustekinumab for Psoriasis?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.